Fulcrum Therapeutics
ID: 5329813Unlocking gene control mechanisms to develop small molecule therapies
3
Funding Rounds
$203.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka** Ha****** | - | - | |
| Ka**** Do**** | - | - | - |
| Al** Ez******* | - | - | - |
| Ja*** Co***** (e************ | - | - | - |
| Ro**** Go*** | - | - | - |
| Br*** St**** | - | - | |
| So*** L. Ba*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Fulcrum Therapeutics has raised a total of $135m in funding over 3 rounds.
Key Insights:
- Fulcrum Therapeutics Series B round, September 2018: $80m
- Fulcrum Therapeutics Series A round, July 2016: $55m
- Fulcrum Therapeutics, Inc. funding round, June 2020: $68.5m
Industries
Fulcrum Therapeutics is active in the following industries: